Pharmacy Daily | Brits slam AMA Rx fears

Other recent headlines

• 

  ACT NIP trial shows pharmacy’s value

  Tuesday | May 26 2020

  PATIENTS are voting with their feet in the ACT and opting to pay a $20 administration charge to receive National Immunisation Program (NIP) funded influenza vaccines, under a trial in the territory, Capital Chemist Group Business Manager, Andrew Topp, reports.

  
• 

  WHO halts hydroxychloroquine trial

  Tuesday | May 26 2020

  LAUDED as a potential cure for COVID-19, the World Health Organization (WHO) has implemented a “temporary pause” of the hydroxychloroquine arm of the multi-national Solidarity Trial, amid safety concerns.

  
• 

  Psychologist lands ban

  Tuesday | May 26 2020

  A VICTORIAN psychologist who used “energy medicine” to treat a patient’s pain, and suggested he develop a relationship with her husband, had been reprimanded and banned from practice for two years.